Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity.
作者信息
DiEuliis Diane, Giordano James
机构信息
Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC, 20057, USA.
Departments of Neurology and Biochemistry and Neuroethics Studies Program-Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, 20057, USA.
出版信息
Protein Cell. 2018 Mar;9(3):239-240. doi: 10.1007/s13238-017-0493-4.
Abstract
摘要
相似文献
1
Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity.
Protein Cell. 2018 Mar;9(3):239-240. doi: 10.1007/s13238-017-0493-4.
2
Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
Mol Genet Genomics. 2017 Jun;292(3):535-536. doi: 10.1007/s00438-017-1300-x.
3
CRISPR-Cas9: New Heights, New Hesitations.
Genet Test Mol Biomarkers. 2018 Nov;22(11):635-636. doi: 10.1089/gtmb.2018.0267. Epub 2018 Nov 15.
4
Exploring the potential of genome editing CRISPR-Cas9 technology.
Gene. 2017 Jan 30;599:1-18. doi: 10.1016/j.gene.2016.11.008. Epub 2016 Nov 9.
5
Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
Clin Chem. 2018 Mar;64(3):489-491. doi: 10.1373/clinchem.2017.278317.
6
Temperature effect on CRISPR-Cas9 mediated genome editing.
J Genet Genomics. 2017 Apr 20;44(4):199-205. doi: 10.1016/j.jgg.2017.03.004. Epub 2017 Mar 30.
7
Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing.
Cells. 2020 Jun 10;9(6):1447. doi: 10.3390/cells9061447.
8
SAA-Cas9: A tunable genome editing system with increased bio-safety and reduced off-target effects.
J Genet Genomics. 2019 Mar 20;46(3):145-148. doi: 10.1016/j.jgg.2019.02.004. Epub 2019 Mar 15.
9
Genome editing of Francisella tularensis using (CRISPR-Cas9).
J Microbiol Methods. 2020 Sep;176:106004. doi: 10.1016/j.mimet.2020.106004. Epub 2020 Jul 18.
10
CRISPR-Cas9 system: A genome-editing tool with endless possibilities.
J Biotechnol. 2020 Aug 10;319:36-53. doi: 10.1016/j.jbiotec.2020.05.008. Epub 2020 May 22.
引用本文的文献
1
Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine.
Front Cell Infect Microbiol. 2025 May 30;15:1588446. doi: 10.3389/fcimb.2025.1588446. eCollection 2025.
2
Genome Editing Dilemma: Navigating Dual-Use Potential and Charting the Path Forward.
J Bioeth Inq. 2024 Jul 24. doi: 10.1007/s11673-024-10358-8.
3
AI in drug discovery: A wake-up call.
Drug Discov Today. 2023 Jan;28(1):103410. doi: 10.1016/j.drudis.2022.103410. Epub 2022 Oct 18.
4
Balancing Act: Precision Medicine and National Security.
Mil Med. 2021 Dec 30;187(Suppl 1):32-35. doi: 10.1093/milmed/usab017.
5
Strengthening the United Nations Secretary-General's Mechanism to an alleged use of bioweapons through a quality-assured laboratory response.
Nat Commun. 2021 May 25;12(1):3078. doi: 10.1038/s41467-021-23296-5.
6
Biothreat & One Health: Current scenario & way forward.
Indian J Med Res. 2021 Mar;153(3):257-263. doi: 10.4103/ijmr.IJMR_583_21.
7
Novel CRISPR-Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives.
Int J Mol Sci. 2021 Mar 24;22(7):3327. doi: 10.3390/ijms22073327.
8
Aerosolized Nanobots: Parsing Fact from Fiction for Health Security-A Dialectical View.
Health Secur. 2019 Jan/Feb;17(1):77-79. doi: 10.1089/hs.2018.0087. Epub 2019 Feb 6.
9
Public Safety and National Security Implications of the Horsepox Study.
Health Secur. 2018 Mar/Apr;16(2):140-142. doi: 10.1089/hs.2018.0018. Epub 2018 Mar 14.
本文引用的文献
1
Rethinking the Biological and Toxin Weapons Convention?
Health Secur. 2017 Nov/Dec;15(6):638-641. doi: 10.1089/hs.2017.0082. Epub 2017 Nov 14.
2
Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.
Protein Cell. 2017 Nov;8(11):791-795. doi: 10.1007/s13238-017-0477-4.
3
U.S. attitudes on human genome editing.
Science. 2017 Aug 11;357(6351):553-554. doi: 10.1126/science.aan3708.
4
Introduction: Testing and Refining Marc Lewis's Critique of the Brain Disease Model of Addiction.
Neuroethics. 2017;10(1):1-6. doi: 10.1007/s12152-017-9310-2. Epub 2017 Mar 2.
5
Why Gene Editors Like CRISPR/Cas May Be a Game-Changer for Neuroweapons.
Health Secur. 2017 May/Jun;15(3):296-302. doi: 10.1089/hs.2016.0120. Epub 2017 Jun 2.
Zotero 插件